Healthcare
NurExone: A Hidden Gem in the $570 Billion Biopharmaceutical Market
NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company developing exosome-based therapies for the multi-billion dollar regenerative medicine market....
3 Hot Biotech Stocks to Watch
Biotech stocks are always on the radar of investors. Imagine investing in a $1 stock that skyrockets to $20, $30, or even higher, thanks...
We warned you about this 1,000%-gain stock!
Something extraordinary occurred on Tuesday—Bright Minds Biosciences (DRUG) surged by an astonishing 1,000%, with a staggering 3,000% gain over the last five days. Incredible,...
Breaking New Ground in Epilepsy Treatment: Bright Minds’ Revolutionary Therapies
Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders. One such therapy involves healing the...
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
Bright Minds Biosciences has announced the commencement of its Phase 2 clinical trial for BMB-101.
On September 25th, the company will host an event to...